Omega-3 polyunsaturated fatty acids impinge on CD4 1 T cell motility and adipose tissue distribution via direct and lipid mediator-dependent effects 1 
. Introduction
Chronic low-grade inflammation is a key feature of cardiovascular metabolic disorders (CVMD), a group of diseases where T cell-mediated adaptive immunity has been considered to play an important role. [1] [2] [3] T cells infiltrate atherosclerotic plaques and obese adipose tissue, driving disease progression through pro-inflammatory immune responses mediated by CD4 þ T-helper type 1 (Th1) and CD8 þ cytotoxic T lymphocytes preponderant over immunomodulatory (Th2) and immu nosuppressive (T regulatory -Treg) immunity. 1, 2 Recruitment and activation of macrophages release of pro-inflammatory cytokines while altered regulatory mechanisms further perpetuate inflammation. 1, 4 As we have recently shown, fat overload leads to a biased differentiation of a proinflammatory effector memory-like population of CD4 þ T cells, both in humans and mice, contributing to the low-grade inflammation observed in obesity. 5 The omega-3 (n-3) polyunsaturated fatty acids (PUFA) eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, found in fish oils, have been explored as means of preventing cardiovascular disease and improving cardiometabolic risk factors. [6] [7] [8] Although the efficiency of n-3PUFA is debated, recent clinical studies have shown that EPA supplementation can reduce the risk of ischemic events and increase the stability of the atherosclerotic plaque, with EPA plaque levels inversely related to their T cell content. [9] [10] [11] [12] Furthermore, n-3PUFA suppress antigen presentation, activation, and proliferation, and lower the expression of cytokines by T cells. [13] [14] [15] While the immunomodulatory properties of n-3PUFA are appreciated, the underpinning molecular mechanisms are not fully understood. Recent findings indicate that EPA induces the differentiation of regulatory T cells through the up-regulation of peroxisome proliferator-activated receptor c, 16 while DHA alters the composition and molecular organization of membrane microdomains, with consequent changes in the activity of signalling proteins linked to actin remodelling, overall, leading to reduced CD4 þ T cell activation. [17] [18] [19] Further to altering membrane composition, n-3PUFA can dispense activities via their metabolism to bioactive lipid mediators of inflammation and immunity, many of which are key players in the cardiovascular system. 17, 20, 21 Membrane esterified omega-6 (n-6) PUFA, such as linoleic acid (LA) and arachidonic acid (AA), compete with n-3PUFA for the same enzymes and yield an array of pro-and anti-inflammatory eicosanoids, octadecanoids, and docosanoids, including pro-resolving mediators (e.g. resolvins, protectins, maresins). [20] [21] [22] Endocannabinoids and other N-acyl ethanolamines (NAE) are PUFA derivatives with strong involvement in the cardiovascular system, inflammation, and immunity. 21, 23 n-3PUFA can also influence the production of ceramides, potent lipid mediators of cell differentiation, and apoptosis, also involved in insulin metabolism and lipotoxicity underpinning cardiovascular disease. [24] [25] [26] Systemically and locally produced lipid mediators interact with T cells through cell surface receptors affecting activation, differentiation, proliferation, cytokine production, motility, and homing events. 21 Examples include the pro-inflammatory and immunosuppressive prostaglandin E 2 (PGE 2 ) that stimulates differentiation of lymphocytes influencing the development and balance of Th1, Th2, and Th17 subsets in a concentration-dependent manner, 21, 27 the endocannabinoid anandamide (AEA) that inhibits T cell proliferation and was shown to be immunosuppressive, 28 and ceramide-1-phosphate (C1P) that promotes cell migration although its effect on T cell function remains to be explored. 29, 30 Modifying the trafficking patterns of activated T cells can promote a less inflammatory environment and improve cardiovascular health; therefore, in-depth understanding of the mechanisms underpinning the n-3PUFA effects on T cell-mediated immune responses is of importance. As well as elucidating the currently debated role of EPA and DHA on cardiovascular health, such detailed insight can support improved interventions and reveal the identity of lipid species with immune-modulatory activities that could instigate the design of novel therapeutics. In this study, we used mice subjected to allogeneic immunization after a diet supplemented with n-3PUFA. Altered distribution of activated CD4 þ T cells in fat tissues revealed the impact of n-3PUFA on the ratio of effector to central memory CD4 þ T cells, while mediator lipidomics revealed bioactive lipids with differing chemotactic properties, formed systemically and in the target tissues. Treating CD4 þ T cells with EPA and DHA ex vivo showed that n-3PUFA could modify membrane microdomains and regulate the signalling events involved in the cytoskeletal dynamics influencing the T cell migratory capabilities.
Materials and methods

Animal study
All in vivo experiments were conducted under the UK Home Office regulation and conformed to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. All animals were euthanized via exposure to rising concentration of CO 2 , according to humane schedule 1 procedures. To study the effect of n-3PUFA supplementation on T cell distribution and composition, wild-type (WT) C57BL/6 female mice were randomly allocated to groups (n = 5 animals per group) fed either chow diet (CD) or CD supplemented with 10% salmon oil (CD þ x3) for 3 weeks (Supplementary material online, Table S1 ) [Special Diet Service (SDS)], as previously reported. 31 Immunization was performed during the third week of supplementation (Section 2.2).
T cell activation
In vitro: murine CD4 þ T cells were isolated with commercially available isolation kits (negative selection; EasySep, Invitrogen) according to the manufacturer's instructions from pooled lymph nodes (inguinal, mesenteric, axillary, brachial, superficial and deep cervical, lumbar, and sacral) and spleen of C57BL/6 female mice and activated with plate bound anti-CD3 (1 mg/mL, eBioscience), anti-CD28 (5 mg/mL, eBioscience), and IL-2 (10 ng/mL, Roche) for 3-4 days; they were then treated overnight with EPA or DHA (free fatty acids dissolved in ethanol) (20 lM; Cambridge Bioscience) as previously reported; 32 this was followed by a treatment with CXCL10 (300 ng/mL) for 1 h with or without methyl-b-cyclodextrin (MbCD; 5 mM; Sigma). Alternatively, on the third day of activation, T cells were treated overnight with the indicated lipid mediators (free forms dissolved in ethanol) (10 nM; Cambridge Bioscience).
In vivo: in WT C57BL/6 female mice fed CD or CD þ x3 for 3 weeks, memory CD4 þ T cells were generated by i.p. immunization with WT Balb/c and CD-1 male splenocytes (1.5 Â 10 6 ) for 7 days. T cells were then isolated from mesenteric (draining) lymph nodes (mLNs), spleen, cardiac fat, perigonadal fat, and subcutaneous fat and used for flow cytometry.
Peritoneal recruitment
In vitro activated CD4 þ T cells were pre-treated with EPA or DHA (20 lM), labelled with 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacri-din2-one) (DDAO) (Invitrogen) and intravenously injected in recipient syngeneic female C57BL/6 mice (5 Â 10 6 cells/mouse) that had 3 h prior received an intraperitoneal injection with CXCL10 (1200 ng/mouse) (n = 4-6 animals); 24 h later, peritoneal lavage and spleen were collected and analysed by FACS for presence of DDAO-labelled T cells.
Membrane and intracellular FACS staining
Spleen samples were lysed of their RBCs before staining. Dead cells were excluded from analysis by staining with fixable Aqua Dead Cell Stain (Invitrogen). Isolated lymphocytes were stained for surface markers: CD4, CD44, CD62L, LFA1, CXCR3, and CD25 ( Figure 1A -F, n = 3-5 animals per group; Figure 4B , n = 4-6, Figure 4C , n = 3 independent experiments; Supplementary material online, Figure S3A -C, n = 3 independent experiments) with fluorescently conjugated primary antibodies (1:200, eBioscience/BioLegend) at 4 C for 30 min in FACS buffer [phosphate buffered saline (PBS) þ 2% FCS þ 0.1% sodium azide] and fixed at 4 C for 30 min with 1% PFA in FACS buffer. For intracellular staining, isolated lymphocytes were incubated in permeabilization/fixation buffer (eBioscience) at 4 C for 1 h. Samples were washed in permeabilization buffer and stained for Foxp3 (1:200, eBioscience/BioLegend) with fluorescently conjugated primary antibodies at 4 C for 30 min in permeabilization buffer. In Supplementary material online, Figure S3D , proliferation of CD4 þ T cells was assessed by dilution of CFSE (3.3 lM, Invitrogen) (n = 9 independent experiments). All samples were then assessed by flow cytometry using an LSRFortessa (BD Biosciences) and FlowJo version 10 software. Dot plots were concatenated to show the independent biological replicates used in each experiment.
Isolation of lymphocytes from fat tissue
Cardiac, perigonadal, and subcutaneous fat were harvested from mice fed CD or CD þ x3 for 3 weeks, cut in small pieces and suspended in a solution of PBS þ 5% BSA containing Collagenase Type II (Sigma) and calcium chloride. Samples were incubated for 20 min at 37 C in agitation to allow tissue digestion; they were then filtered through a 70 lm cell strainer and the collected cell suspension was washed and stained for FACS analysis. Any blood contamination was removed by lysis of red cells with RBC lysis buffer. The weight of the fat tissues harvested from all animals used is shown in Supplementary material online, Table S2 .
Chemotaxis
Chemotaxis assays were performed in 5 lm transwell inlays (Corning). In vitro activated lymphocytes were suspended in migration medium (RPMI 2% FCS) and seeded in the upper transwell chamber (3 Â 10 5 cells/transwell). Chemokine CXCL10 (300 ng/mL) (PeproTech) was added to the lower chamber, or alternatively the indicated lipid mediators at a concentration of 10 nM or other as indicated. Migrated T cells were counted with a haemocytometer at 2, 4, and 6 h after seeding, and then the percent of migrated cells was calculated (n = 7 animals in Figure  3A and B; n = 3 animals in Figure 4D ). In some assays, microvascular endothelial cells (isolated from the lungs of C57BL/6 mice) were seeded (3 Â 10 4 cells/well) on 3 lm transwell inlays. 33 On the following day, T cells (3 Â 10 5 cells/well) suspended in migration medium were added to the top chamber of the transwell and incubated at 37 C with 5% CO 2 to allow migration through the endothelial monolayers. Migrated T cells were counted with a haemocytometer at 6 and 24 h after seeding, then the percent of migrated cells was calculated ( Figure 4A , n = 3 independent experiments).
Cytotoxicity assay
Cytotoxicity was assessed by the MTT assay performed using the CellTiter 96 AQueous One Solution Cell Proliferation colorimetric assay (Promega), according to the manufacturer's instructions. Briefly: in vitro activated T cells (5 Â 10 4 cells) were treated overnight with increasing fatty acid concentrations (1-100 lM); they were then seeded into each well of a 96-well plate and CellTiter 96 AQueous One Solution reagent was added (20 lL per well). After 1 h incubation, absorbance (490 nm) was measured in a microplate reader (n = 3 independent experiments; Supplementary material online, Figure S3F ).
Western blot
Protein lysates were prepared from CD4 þ T lymphocytes isolated from pooled lymph nodes and activated as described above. Samples were lysed in Nonidet P-40 lysis buffer (50 mM HEPES pH 8.0, 350 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 1 mM Na 3 VO 4 , 1 mM NaF, 20 mM glycerol-2-phosphate, 1 mM PMSF, 1 mM DTT, 10 mg/mL aprotinin, 10 mg/mL leupeptin, and a protease inhibitor mixture; Roche). Equivalent amounts of protein as determined by standard Bradford assay (Bio-Rad) were separated by SDS/PAGE and transferred to a Nylon membrane (GE Healthcare). Membranes were blocked for 1 h at room temperature in 5% Milk/TBS-T, incubated overnight at 4 C with primary antibodies (1:1000), and subsequently with horseradish peroxidase-conjugated secondary antibody (Amersham Bioscience) (1:5000). Antibodies against Rhoa and Rac1 were purchased from Cytoskeleton, Inc. p-PAK1/2, p-MLC2, and b-actin were purchased from Cell Signalling. Pull-down of the active form of Rhoa and Rac1 were performed, respectively, with Rhotekin-RBD protein GST beads and PAK-GST protein beads according to the manufacturer's instruction.
Immunofluorescence
CD4 þ T cells isolated from lymph nodes and spleen of C57BL/6 female mice were activated in vitro for 3 days; on the third day of activation, cells were treated overnight with EPA, DHA, or oleic acid (20 lM) (n = 3 independent experiments). The day after, cells were treated with CXCL10 300 ng/mL for 1 h and, where indicated, with MbCD (5 mM; Sigma) (n = 3 independent experiments); then cells were suspended in PBS and allowed to attach for 1 h in incubator at 37 C onto coverslips pre-treated with Cell-tack (Corning). Cells were then washed, fixed in 3.7% PFA for 20 min, permeabilized with PBS containing 0.2% Triton X-100, blocked with PBS containing 1% BSA and 0.02% Triton X-100 for 30 min and incubated with 6.6 lM Phalloidin (F-actin staining, Thermo Fisher Scientific) and 0.3 lM DnaseI (G-actin staining, Thermo Fisher Scientific) for 30 min. Anti-Rhoa (Cytoskeleton, Inc.) mouse antibody was incubated for 2 h (1:100) and revealed with anti-mouse Alexa fluor 569 for 45 min. Nuclei were stained with DAPI (300 nM; Thermo Fisher Scientific). Finally, coverslips were mounted onto slides using a DAKO mounting medium. Images were acquired using a confocal microscopy and analysed using ZEN software; in Supplementary material online, Figure S5 , images were acquired using a fluorescence microscope (Leica AF60000) and LAS X Software.
Mediator lipidomics
Extraction and analysis of prostanoids and hydroxy fatty acids was performed as described previously. 34, 35 Briefly, plasma (100-200 lL) or solid tissue (20-60 mg) samples (n = 6 animals per group) were homogenized in ice-cold methanol (15% v/v), spiked with a mixture of deuterated internal standards (40 ng each of 12-HETE-d8, 8,9-DHET-d11, Omega-3 fatty acids impact CD4 þ T cell trafficking and adipose tissue distribution ceramides (C), sphingoid bases and phosphorylated ceramides (D) found in fat tissue, lymphoid organs, and plasma. Tissue was obtained from female C57BL/ 6 WT mice fed a chow (CD) or chow with 10% salmon oil (CD þ x3) diet. Data are expressed as ng/mg protein in solid tissues and ng/mL in plasma. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 based on multiple t-tests followed by Holm Sidak post-hoc correction (n = 6 animals per group).
Omega-3 fatty acids impact CD4 þ T cell trafficking and adipose tissue distribution . . . . . . . . 8,9- EET-d11, and PGB 2 -d4) and incubated in the dark. Solid phase extraction (SPE) (C18 cartridges; Phenomenex, Macclesfield, UK) was used to clean-up the supernatants, which were then acidified and added to the pre-conditioned SPE cartridges. Lipids were eluted with methyl formate and analysed by ultrahigh performance chromatography (UPLC; Acquity, Waters, USA) coupled to a triple quadrupole mass spectrometer with an electrospray ionization source (Xevo TQS, Waters) (UPLC/ ESI-MS/MS) in the negative ionization mode on a C18 column (Acquity UPLC BEH C18; 50 Â 2.1 mm, 1.7 lm; Waters, UK). Instrument and data analysis were carried out by TargetLynx software (Waters, UK). Data reported were normalized with the use of internal standards and quantified using internal calibration curves constructed with commercially available standards.
Extraction and analysis of endocannabinoids, NAE, 2-monoacylglycerols (MG), ceramides, phosphorylated ceramides, phosphorylated bases, and free sphingoid bases were performed as described. 34 Waters, UK) for endocannabinoids and NAE, and a C8 column (Acquity UPLC BEH C8; 100 Â 2.1 mm; 1.7 lm; Waters, UK) for ceramides; all in the positive ionization mode. In the case of solid tissues the organic layer was cleaned up by SPE (Strata SI-1-Silica; Phenomenex, Macclesfield, UK) before their analysis by UPLC/ESI-MS/MS. Instrument and data analysis were carried out by TargetLynx software (Waters, UK). Data reported were normalized using internal standards; endocannabinoids, 2-MG, and NAE were quantified using internal calibration curves constructed with commercially available standards; relative quantification of ceramides was performed using internal standards.
Protein content was performed on the protein pellets retained during the lipid extractions using protein assay kit (Bio-Rad, Hemel Hempstead, UK), as described. 34 
Isolation and lipid analysis of detergent-resistant membrane microdomains
The insolubility of membrane microdomains in non-ionic detergents, such as Brij-58, at 4 C is the most common method used to isolate detergent-resistant membranes (DRM); low density DRM are a crude representation of 'lipid raft microdomains'. Here, DRM were isolated from murine T cells ( Figure 6A , n = 4 independent experiments; Figure 6B and C, n = 5 independent experiments) as described before. 37 Chemotaxis assay of in vitro activated CD4 þ T cells isolated from pooled lymph nodes and spleens of female C57BL/6 WT mice in response to the cytokine CXCL10 (300 ng/mL), the eicosanoids PGE 2 and 12-HEPE, the octadecanoid 9-HOTrE, the docosanoid 19, 20-DiHDPA, the endocannabinoid AEA, and C1P N(16)S(18)C1P (10 nM), the combination of the cytokine and lipid treatment, or media only (indicated by the red line; CTRL). In (A), lipid mediators are tested for their ability to affect CD4 þ T cells migratory capabilities; conversely, in (B) their capacity to counteract or synergize with CXCL10 is measured. The number of migrated cells is reported as a percentage normalized to media only control. Two-tailed Student's t-test (n = 7 independent experiments). The values denote mean ± SEM. *P < 0.05; **P < 0.01 vs. CTRL (red line); and # P < 0.05 vs. CXCL10 (B). TargetLynx software (Waters, UK). Data processing was carried out using Progenesis QI (Waters), which aided TIC-based chromatogram alignment and peak picking. Lipid identification was performed and confirmed through fragmentation patterns, using the LIPID MAPS database and in-house information. Relative quantification was estimated using deuterated internal standards.
Statistical analysis
Data are expressed as mean ± standard error of the mean (SEM), using n = 3-6 animals per group (Figures 1, 2, and 4) and n = 3-7 independent experiments per group (Figures 3-7) , unless otherwise stated in the methods section. Data distribution was assessed for normality using the Shapiro-Wilk and Kolmogorov-Smirnov normality tests. For the cell and animal studies, the data were parametric. The lipidomics data were mainly parametric although the distribution of some lipid species in some of the tissues examined was not parametric. We therefore analysed the data with parametric and non-parametric tests and performed sensitivity tests in the raw and log transformed data; in all cases we came up with similar results, therefore the initial analysis using parametric tests was applied. The tests used were two-tailed Student's t-tests and multiple t-tests with Holm Sidak post-hoc test for multiple comparisons or one-way ANOVA with Tukey post-hoc test. All analyses were performed using GraphPad Prism version 7.00. In all cases, a P-value of <0.05 was considered to be significant.
Results
Tissue distribution of CD4 þ T cells post n-3PUFA supplementation
The effect of n-3PUFA supplementation on the distribution of the main CD4 þ T cell subsets in adipose tissues and lymphoid organs was examined. No major changes in body parameters, including weight, were observed after 3 weeks of CD þ x3 diet compared to CD, which was in line with our previous data. 6 Lymphoid organs (spleen and mLNs) and adipose tissue from different areas of the body, namely the heart (cardiac fat), lower peritoneum (perigonadal fat), and skin (subcutaneous fat) were harvested 7 days after immunization and the number and subtypes of CD4 þ T cells were assessed by FACS. We found that, in the n-3PUFA supplemented animals (CD þ x3 group), the overall number of CD4 þ T cells (as normalized to fat tissue weight; Supplementary material online, Table S2) , was not significantly different as compared to untreated controls (CD group); similarly, no difference was observed in the number of CD4 þ T cells found in the lymphoid organs ( Figures 1A and Supplementary material online, Figure S1A ).
Dietary supplementation with n-3PUFA also led to a reduction in the relative abundance of activated memory CD44 þ T cells (assessed as % of total CD4 þ T cells), both in fat (with the only exception of perigonadal fat) and lymphoid tissues ( Figure 1B and Supplementary material online, Figure S1B) . Importantly, the n-3PUFA diet altered the balance between central and effector memory CD4 þ T cell populations in the fat tissues examined, leading to a statistically significant reduction in the CD44 hi CD62L lo (cardiac fat P < 0.001, subcutaneous fat P < 0.001, mLNs P < 0.01) and CD44 þ LFA1 þ (cardiac fat P < 0.05, subcutaneous fat P < 0.05) effector memory CD4 þ T cell population, while it increased the CD44 hi CD62L hi central memory CD4 þ T cell subset (cardiac fat P < 0.01, perigonadal fat P < 0.05, subcutaneous fat P < 0.05) ( Figure 1C-E and Supplementary material online, Figure S1C and D, respectively) . Furthermore, analysis of the regulatory CD25 þ Foxp3 þ (Treg) CD4 þ T cells, showed a trend towards an increase in the Treg population found in the fat tissues of animals fed the n-3PUFA-supplemented diet, as compared to animals fed standard CD ( Figure 1F and Supplementary material online, Figure S1E ).
Tissue profiling of lipid mediators post n-3PUFA supplementation
As CD4 þ T cell function may be affected by chemotactic lipid mediators, we employed lipidomics performed by UPLC/ESI-MS/MS [34] [35] [36] 39 to analyse various eicosanoids, docosanoids, octadecanoids, endocannabinoids, NAE, 2-MG, ceramides, and sphingoid bases, in plasma, spleen, lymphoid, and adipose tissues of the animals fed CD and CD þ x3 diets ( Figure 2) .
Although mLNs and spleen had the largest number and diversity of cyclooxygenase-derived (COX) prostanoids and lipoxygenase (LOX-) and cytochrome P450 (CYP-) hydroxy-and epoxy-fatty acids detected (all members of the eicosanoid, octadecanoid, and docosanoid classes), cardiac, perigonadal, and subcutaneous fat and plasma appeared to produce the most abundant species at higher concentrations (Figure 2A) . The n-3PUFA diet reduced levels of AA-derived prostanoids and increased EPA-and dihomo-c-linolenic acid (DGLA)-derived species in all tissues examined. Specifically: statistical significant decrease of PGF 2a in cardiac fat (P < 0.0001) and spleen (P < 0.01), PGE 2 in perigonadal fat (P < 0.05), and prostacyclin (measured as 6-keto PGF 1a ) in cardiac fat (P < 0.01) were observed, while levels of 8-iso-PGF 2a (P < 0.01), PGE 3 (P < 0.001), and TXB 3 (P < 0.01) in spleen and PGD 3 (P < 0.01) in mLNs were significantly increased. Furthermore, the n-3PUFA supplementation reduced most AA-, a-linolenic acid-and DGLA-derived mediators formed via the LOX and CYP pathways, with concomitant increases in DHA-, EPA-and LA-derived species. The following mediators were significantly increased: 9-HOTrE in cardiac fat (P < 0.01) and mLNs (P < 0.001); 7-HDHA (P < 0.01) in mLNs; 11-HDHA (P < 0.001) in mLNs; 5-HEPE in mLNs (P < 0.001), spleen (P < 0.01), and plasma (P < 0.001); 20-HDHA in mLNs (P < 0.01) and plasma (P < 0.01); 11-HEPE in mLNs (P < 0.001) and spleen (P < 0.001); 18-HEPE in mLNs (P < 0.0001), spleen (P < 0.0001), and plasma (P < 0.01); and 19,20-DiHDPA in mLNs (P < 0.0001) and spleen (P < 0.001). 15-HETE was significantly decreased in spleen (P < 0.001).
Due to limited sample availability, endocannabinoids, NAE, 2-MG, and ceramides were only analysed in perigonadal and subcutaneous fat, spleen, and plasma ( Figure 2B-D) . Although plasma showed the highest concentrations of 2-MG species, 2-AG was found mostly in spleen. Interestingly, the fish oil diet significantly reduced production of AEA (P < 0.001) in perigonadal fat, while the n-3PUFA-derived species DPEA (P < 0.001) and 2-DHG (P < 0.0001) were significantly increased in spleen ( Figure 2B) . (P < 0.01), and C18S (P < 0.01) were lower in subcutaneous fat; and N(18)S(18) (P < 0.001) was reduced in spleen. Additionally, a significant reduction was observed in ceramides with C22 fatty acyl chain (P < 0.01) in plasma and a significant increase in ceramides with C16 fatty acyl chain (P < 0.01) in subcutaneous fat, in the n-3PUFA fed group compared to mice fed on CD (Supplementary material online, Figure S2 ).
n-3PUFA and related mediators directly affect T cell motility and trafficking
The observed altered tissue distribution of CD4 þ T cells can be caused by EPA and/or DHA-induced changes in the production of chemotactic lipid mediators, both systemically and in the target fat tissues. We therefore examined the activity of selected lipid species, namely: the eicosanoids PGE 2 , 12-HEPE and 18-HEPE, the octadecanoid 9-HOTrE, the docosanoid 19, 20-DiHDPA, the endocannabinoid AEA, and the C1P N(16)S(18)C1P, and assessed their ability to affect the motility of CD4 þ T cells in ex vivo assays. The bioactive lipids selected represent the classes of mediators that were found mostly affected by the fish oil diet; their activity was assessed at a single concentration (10 nM) that corresponds to the lower level these mediators were found in the tissues analysed (Figures 2, 3, and 4D) .
Lipid mediators can act as chemoattractants but can also affect the migratory response of T cells to chemokines; 30, [40] [41] [42] [43] we therefore assessed both potential modalities of action. When tested for their chemotactic activity, 19,20-DiHDPA, AEA, and N(16)S(18)C1P appeared to significantly increase the migratory response of activated CD4 þ T cells ( Figures  3A and 4D ). Conversely, when tested for their ability to interfere with the migratory response to the control chemokine CXCL10, CD4 þ T cells pre-treated with 9-HOTrE and PGE 2 showed reduced ability to migrate, compared to CXCL10 alone ( Figure 3B) .
EPA and DHA were also assessed for their direct impact on the ability of CD4 þ T cells to migrate across an endothelial monolayer. Activated Omega-3 fatty acids impact CD4 þ T cell trafficking and adipose tissue distribution CD4 þ T cells were treated with EPA and DHA (20 lM; 16 h) and allowed to interact with interferon-c-primed endothelial monolayer. Both EPA and DHA reduced the trans-endothelial migration of CD4 þ T cells, at 6 h and 24 h after seeding, compared to vehicle control ( Figure  4A ). This effect was weaker at 24 h showing that the n-3PUFA-induced inhibition is reversible. Furthermore, both EPA and DHA pre-treated cells showed impaired traffic to the inflamed peritoneum, in vivo ( Figure  4B) . Moreover, the n-3PUFA treatment reduced the proportion of CXCR3 þ (CXCL10 receptor) in the population of fluorescently labelled CD4 þ T cells that had reached the peritoneum (Figure 4C) , while no difference was observed in the CD44 high CCR7 low or CD44 high CD62L low CD4 þ T cells (Supplementary material online, Figure S3A ). The inhibitory effect of n-3PUFA to the chemotactic response to CXCL10 was specific as no effects were observed with the monounsaturated fatty acid oleic acid or the saturated fatty acid palmitic acid ( Figure 4D) .
Finally, we assessed whether EPA and DHA could induce the differentiation of CD4 þ T cells to a central memory subset which would explain the reduced migration through an activated endothelium as well as the reduced trafficking to the CXCL10-enriched peritoneum. However, we did not observe any significant effects (Supplementary material online, Figure S3B and C). Furthermore, treatment with EPA and/or DHA (20 lM, 16 h) (Supplementary material online, Figure S3D and E), or with a 1-100 lM concentration range of EPA, or oleic acid or palmitic acid (Supplementary material online, Figure S3F ) did not alter proliferation or survival of CD4 þ T cells as compared to vehicle treatment.
EPA and DHA affect cell polarization and cytoskeleton dynamics
The impact of EPA and DHA on cytoskeletal dynamics, a process underpinning all migratory events, was explored using CD4 þ T cells treated with EPA, DHA (20 lM) in vitro. Actin remodelling was followed by staining of filamentous actin (F-actin) and globular actin (G-actin), the two main forms actin is present in cells ( Figure 5A, left) . The n-3PUFA treatment caused a reduction in the number of polarized CD4 þ T cells, i.e. cells with a leading edge (pseudopod), in the presence of the promigratory stimulus CXCL10 ( Figure 5A, top right) . Although a similar trend was observed in the absence of CXCL10, the number of spontaneously polarized cells was low, and the results did not reach statistical significance (Supplementary material online, Figure S4A ). Furthermore, the F-actin/G-actin ratio-a measure of how dynamic the cytoskeleton is-was also reduced by both EPA and DHA, consistent with the observed reduced polarization ( Figure 5A, bottom right) . The monounsaturated fatty acid oleic acid did not show the same effect as EPA or DHA on cell morphology (Supplementary material online, Figure S5 ), confirming the specificity of n-3PUFA.
Further mechanistic insight was sought by analysing the expression of the small Rho GTPase, Rhoa and Rac1, two key orchestrators of cell polarization and migration. 44, 45 Treatment of activated CD4 þ T cells with EPA and/or DHA in the presence or absence of CXCL10, caused a reduction of Rhoa and Rac1 total protein levels as well as of the active, GTP-bound form, which is responsible of the regulation of the cytoskeletal dynamics ( Figure 5B and C and Supplementary material online, Figure  S4B) .
To assess the potential functional consequences of the observed n-3PUFA-induced Rhoa and Rac1 down-regulation, we analysed the phosphorylation levels of the downstream target of Rhoa and Rac1, MLC2 and PAK1/2, respectively, [46] [47] [48] and found that they were both decreased ( Figure 5B and C) . Finally, staining Rhoa and F-actin in EPA-and DHA-treated CD4 þ T cells, with or without CXCL10, showed distinct patterns of localization of Rhoa: while most untreated control cells were polarized with Rhoa mainly found at the pseudopods (Figure 5D ), the majority of EPA-and DHA-treated cells had a round shape with Rhoa showing an even distribution along the cell membrane or in the cytoplasm ( Figure 5D ).
3.5 n-3PUFA affect the distribution of glycerophospholipids and SMs in CD4 þ T cell membrane microdomains EPA and DHA can modify the lipid composition of the plasma membrane and this can affect the formation and structure of the membrane microdomains important for delivering signals that modify the cytoskeletal dynamics. [49] [50] [51] [52] The impact of n-3PUFA on the lipid composition of CD4 þ T cell membrane microdomains was explored through profiling of membrane lipids by UHPSFC/ESI-QTOF-MS E . For this, we analysed the relative abundance and distribution of glycerophospholipids, sphingolipids, and acylglycerides in DRM fractions prepared from CD4 þ T cells treated ex vivo with EPA, DHA (20 lM), or vehicle (control) using a sucrose gradient ( Figure 6 and Supplementary material online, Figures  S6-S8) . The low density DRM separated in Fr. 1-3 roughly represent 'lipid rafts'. 37 In control untreated T cells, the predominant SM species were SM 34:1, SM 36:1, SM 38:4, SM 42:2, and SM 46:7 ( Figure 6A) . Figure S6C ). Finally, triacylglycerides were found mostly in either the DRM (Fr. 1-3) or DSM (Fr. 8-10) fractions (Supplementary material online, Figure S6E ), whereas diacylglycerides were found mostly accumulated in the intermediate density fractions (Fr. 4-7) (Supplementary material online, Figure S6F ).
Treatment with DHA altered the lipid composition of the membrane microdomains, across the sucrose gradient fractions ( Figure 6A-D and Supplementary material online, Figures S6A-F, S7, and S8) . Although the distribution of total phospholipids and acylglycerides did not change, the relative abundance of lipid species was altered. In detail: DHA caused an enrichment of monounsaturated SM, PC, and PE species in the DRM fractions and reduced polyunsaturated PC species in the intermediate density fractions (Fr. 4-7) (P < 0.05) and monounsaturated PE species in the DSM fractions (Fr. 8-10) (P < 0.05), all compared to untreated controls ( Figure 6D and Supplementary material online, Figure S8 ). Conversely, EPA was less effective that DHA and had no effect on the re-distribution of SM and PC species, although it appeared to shift monounsaturated PE species to the DRM (Figure 6A and Supplementary material online, Figure S6C ). The observed changes suggest that DHA is more 
Lipid microdomain disruption exerts the same effect as EPA and DHA treatment
The impact of EPA and DHA on membrane microdomains may also disrupt the signalling pathways to Rho GTPase proteins downstream of chemokine signalling. 52 To test this hypothesis, CXCL10-stimulated CD4 þ T cells were treated in vitro with the cyclodextrin MbCD, a high molecular weight cyclic oligosaccharide able to deplete cholesterol from biological membranes, thus impeding lipid microdomain formation. 53 This resulted in a reduction in cell polarization and F-actin/G-actin ratio, similar to that observed following T cell treatment with EPA and DHA ( Figure 7A) . The expression of the small Rho GTPase, Rhoa, and Rac1 was also reduced ( Figure 7C) while the cellular distribution of Rhoa was altered in a way similar to the EPA and DHA treatments, showing an even distribution around the plasma membrane as compared to the pseudopod accumulation in the CXCL10-treated cells ( Figure 7B ).
Discussion
The importance of adaptive immunity in the establishment of a chronic, low-grade inflammation in CVMD is now becoming clear and new interventions are needed to combat this unwanted inflammatory response and re-establish physiological tissue homeostasis. The anti-inflammatory protective effects of n-3PUFA extend to the cardiovascular and immune systems, and here we examined their impact on the properties and tissue distribution of CD4 þ T cells, crucial orchestrators of inflammatory responses in cardiometabolic disease.
The n-3PUFA supplementation modified the balance among the T cell populations reducing the pro-inflammatory T cells in most of the fat tissues examined; this was accompanied by a concomitant increase in the central memory CD44 hi CD62L hi CD4 þ T cells (Figure 1) . Our findings support the anti-inflammatory profile of n-3PUFA suggesting that their activities are mediated, at least in part, through changes in T cell properties including motility. Although not assessed here, n-3PUFA supplementation is considered beneficial in other organs including the liver where it has been shown to confer protection against damage in the setting of steatosis and high-fat diet by reducing ceramide production and regulating sphingolipid biosynthesis. 54, 55 N-3PUFA can modify the network of bioactive lipid mediators, both locally and systemically, altering the prevalence of chemotactic lipid species with consequence for the migratory capacity of T cells. 21 Profiling the mediator lipidome in the target lymphoid and fat tissues, and plasma, showed reduction of AA-derived mediators, together with increased production of EPA-and DHA-derived species, and reduction of ceramides ( Figure 2) . While AA mediators are considered pro-inflammatory, their EPA and DHA counterparts appear to be either less potent or present anti-inflammatory protective profiles, and reduced levels of ceramides have been linked to improvement in cardiovascular disease. 20, 21, 26 Changes in the composition of the tissue lipid milieu may have affected the distribution pattern of locally detected CD4 þ T cells, therefore selected bioactive lipid species were assessed for their potency as chemoattractants as well as for their ability to interfere with the effect of CXCL10, a potent inflammatory chemokine. In the absence of any other migratory stimulus, 19,20-DiHDPA, AEA and N(16)S(18)C1P increased the migration of CD4 þ T cells in vitro ( Figure 3A) . The endocannabinoid AEA and C1P N(16)S(18)C1P were found reduced by the n-3PUFA treatment in perigonadal and subcutaneous fat, and this may have led to the decrease in CD44 þ T cells found in fat tissues (Figure 1) . 19,20-DiHDPA, a product of DHA, was increased post-supplementation in all tissues examined, and its ability to act as chemoattractant may have also contributed to the CD4 þ T cells subtype profiles observed in lymphoid and fat tissues. 18-HEPE, a product of EPA and precursor of proresolving mediators was also increased post-supplementation. 56 However, unlike 19,20-DiHDPA, AEA and N(16)S(18)C1P, 18-HEPE did not have any effect on the migratory response of activated CD4 þ T cells. Although other studies have shown the activity of EPA-and DHAderived pro-resolving lipids (e.g. RvE and RvD), these were not identified in the tissues analysed, suggesting that, if formed, their levels were below the level of detection of the assays used in our experimental settings. 56, 57 Our findings (Figure 1) are the result of multiple changes in the network of lipid mediators, all occurring as a result of the n-3PUFA diet, and the exact contribution and properties of individual species should be further explored. When assessed in the presence of CXCL10, the octadecanoid 9-HOTrE and eicosanoid PGE 2 were able to counteract the potent effect of this chemokine ( Figure 3B ). While 9-HOTrE was found increased post n-3PUFA, the levels of PGE 2 were reduced (Figure 2A) , showing the differential contribution of various lipid mediators in the anti-inflammatory effect of n-3PUFA diets. It is therefore evident that the metabolism of n-3PUFA and subsequent perturbation of bioactive lipids have diverse effects on the migratory ability of T cells, but the overall balance is towards an anti-inflammatory protective effect suggesting that dietary supplementation may regulate the function of T cells.
Further to their metabolism to bioactive mediators, EPA and DHA may also be directly involved in the regulation of T cell migration. As shown (Figure 4) , both fatty acids can down-regulate the migratory capability of activated CD4 þ T cells, ex vivo and, more importantly, in vivo, in a peritoneal recruitment assay, suggesting that some of their antiinflammatory effects may be attributed to inhibition of immune cell migration. Interestingly, at least in vitro, EPA and DHA do not interfere with the differentiation of CD4 þ T cell subsets, or with their proliferation and survival. Therefore, the different T cell subsets found in adipose and lymphoid tissues of n-3PUFA fed mice could be due to the effect of fatty acids on trafficking rather than differentiation.
EPA and DHA could also act at cellular level altering the ability of T cells to respond to migratory stimuli. Analysis of the polarization of activated and CXCL10-stimulated CD4 þ T cells showed that treatment with EPA or DHA reduced formation of pseudopods and decrease the ratio between F-actin and G-actin, a measurement of cellular dynamicity. 45 Moreover, this change happened in concomitance with the downregulation of Rhoa and Rac1, two small Rho GTPases involved in cell migration ( Figure 5) . These findings show that EPA and DHA can interfere with the molecular machinery necessary for migration to occur, and although the exact signals triggered are not yet known, our results demonstrate that n-3PUFA have a direct impact on cytoskeletal rearrangements.
The observation that EPA and DHA down-regulate the expression rather than activity of Rhoa and Rac1 ( Figure 5B and C) suggest that they trigger signals able to interfere with Rhoa and Rac1 transcriptional or post-translational regulation; elucidation of these molecular signals and their control mechanisms requires further investigation. However, the consequent decrease in phosphorylation of two downstream targets, Omega-3 fatty acids impact CD4 þ T cell trafficking and adipose tissue distribution
